Praxis Precision Medicines Inc.

PRAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$305.03

+$6.16 (+2.06%)

Sep 22, 2026, 11:09 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ACAD ACADIA Pharmaceuticals	N/A
IMVT Immunovant	N/A
KYMR Kymera Therapeutics	N/A
LGND Ligand Pharmaceuticals Incorporated	N/A
VKTX Viking Therapeutics	N/A
XENE Xenon Pharmaceuticals	N/A

Dividend Rankings ➞

Recent News

1 day ago / defenseworld.net
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Recommendation of “Moderate Buy” by Brokerages
27 days ago / defenseworld.net
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Buy” from Brokerages
2 months ago / seekingalpha.com
Praxis: Commercial Launch Could Smash Expectations (Video)
2 months ago / seekingalpha.com
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript
2 months ago / marketbeat.com
Praxis Precision Medicines Q2 Earnings Call Highlights
2 months ago / globenewswire.com
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
2 months ago / seekingalpha.com
Praxis Precision Medicines: Priced For Half Of What I Think It's Worth
3 months ago / globenewswire.com
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
3 months ago / globenewswire.com
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
3 months ago / benzinga.com
Praxis' Seizure Drug Move Towards Faster Development After Positive Trial Results